NCT05069805

Brief Summary

Ultrasound-guided blockage of the erector plane of the spine (known as ESP BLOCK) is a recently described block and a very useful strategy in the perioperative period as it provides effective analgesia in thoracic surgery. Ultrasound-guided type II pectoral nerve block (internationally known by the acronym Pecs II block) is a very useful strategy in the perioperative period because it provides effective analgesia in breast surgeries and can optimize results. The aim of this study is to assess perioperative pain in mastectomies. This is a prospective, randomized, single-blinded study that will compare the effects of spinal erector plane block versus pectoral nerve block in patients scheduled for mastectomy. The ESP group will receive balanced general anesthesia associated with ESP BLOCK with 0.5% ropivacaine guided by ultrasound. The Pecs II group will receive balanced general anesthesia associated with Pecs II block with 0.5% ropivacaine guided by USG.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 6, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

November 5, 2021

Status Verified

October 1, 2021

Enrollment Period

11 months

First QC Date

September 25, 2021

Last Update Submit

October 29, 2021

Conditions

Keywords

Acute painChronic painMastectomy

Outcome Measures

Primary Outcomes (1)

  • Analgesic consumption during surgery

    The amount of opioid analgesics consumed during surgery

    During the surgery

Secondary Outcomes (7)

  • Anesthetics consumption during surgery

    During the surgery

  • Tramadol consumption in post-operative

    Within the first 24 hours after surgery

  • Pain Scores on the Numeric Rating Scale

    Within the first 24 hours after surgery

  • Number of participants with adverse events as a measure of safety and tolerability

    During the surgery

  • Number of participants with adverse events as a measure of safety and tolerability

    Within the first 24 hours after surgery

  • +2 more secondary outcomes

Study Arms (2)

PECS II block group

ACTIVE COMPARATOR

Patients in PECS II group will receive general balanced inhaled anesthesia with sevoflurane and fentanyl

Procedure: PECS II blockProcedure: ESP block

ESP block group

ACTIVE COMPARATOR

Patients in ESP group will receive general balanced inhaled anesthesia with sevoflurane and fentanyl

Procedure: PECS II blockProcedure: ESP block

Interventions

PECS II blockPROCEDURE

Patients will receive standard general anesthesia with sevoflurane and fentanyl associated to PECS II block

ESP block groupPECS II block group
ESP blockPROCEDURE

Patients will receive standard general anesthesia with sevoflurane and fentanyl associated to ESP block

ESP block groupPECS II block group

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients, aged between 18 and 70 years, electively scheduled for mastectomy at Hospital Regional de Sobradinho and Hospital de Base do Distrito Federal;
  • American Society of Anesthesiology (ASA) physical status I, II or III

You may not qualify if:

  • Patient with severe heart disease;
  • Patient with severe liver disease;
  • Patient with severe kidney disease;
  • Patient with a neurological disease;
  • Use of psychoactive drugs;
  • Pregnant women;
  • Patients with allergies to any medication used in the study;
  • Patients with chronic pain;
  • Patients who refused to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Base do Distrito Federal

Brasília, Federal District, 70330150, Brazil

RECRUITING

Related Publications (1)

  • Sinha C, Kumar A, Kumar A, Prasad C, Singh PK, Priya D. Pectoral nerve versus erector spinae block for breast surgeries: A randomised controlled trial. Indian J Anaesth. 2019 Aug;63(8):617-622. doi: 10.4103/ija.IJA_163_19.

    PMID: 31462806BACKGROUND

MeSH Terms

Conditions

Acute PainChronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marcus Alexandre Avis, MD

    Hospital de Base do Distrito Federal

    STUDY DIRECTOR

Central Study Contacts

Fabrício T Mendonça, MD, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The researcher responsible for the postoperative period, the surgical team and the patients were not aware of the allocated groups. The researcher responsible for the randomization list communicated the researcher responsible for performing the ESP or PECS II block and conducting the anesthesia.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized, single-blind, superiority study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiology Residency Preceptor

Study Record Dates

First Submitted

September 25, 2021

First Posted

October 6, 2021

Study Start

October 1, 2021

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

November 5, 2021

Record last verified: 2021-10

Locations